RA Capital Management, L.P. 13D/13G Filings for Bright Minds Biosciences Inc. (DRUG)

RA Capital Management, L.P. 13D and 13G filings for Bright Minds Biosciences Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-12
4:15 pm
Purchase
2024-11-0413GBright Minds Biosciences Inc.
DRUG
RA Capital Management, L.P.460,829
6.600%
460,829increase
(New Position)
Filing